期刊文献+

小牛脾提取物联合奥沙利铂方案治疗晚期结肠癌的临床观察 被引量:1

CLINICAL RESEARCH OF CALF SPLEEN EXTRACTIVE COMBINED WITH OXALIPLATIN SCHEME IN TREATING CARCINOMA OF COLON
原文传递
导出
摘要 目的探讨小牛脾提取物联合奥沙利铂方案治疗晚期结肠癌的疗效以及对T淋巴细胞亚群的影响。方法本研究收集晚期结肠癌患者95例,随机分为对照组47例和观察组48例。对照组:给予奥沙利铂化疗方案。观察组:在对照组基础上予小牛脾提取物注射液,1次/d,连用8周。比较二组生活质量评分、不良反应及临床疗效。检测二组血清T淋巴细胞亚群水平。结果治疗后观察组症状指标评分明显低于对照组,功能指标评分显著高于对照组(P<0.01)。观察组总有效率为89.58%,明显高于对照组70.21%(P<0.05)。观察组患者的不良反应发生率均少于对照组,且胃肠道反应、血小板减少、白细胞减少发生率明显少于对照组(P<0.05)。治疗后3个月,观察组患者的CD3+、CD4+水平明显高于治疗前和对照组同期水平,而CD8+显著减少,比较差异有统计学意义(P<0.01)。结论小牛脾提取物联合奥沙利铂方案治疗晚期结肠癌的疗效显著,上调患者的T淋巴细胞亚群水平可能与之有关。 Objective To investigate efficacy of Calf spleen extractive combined with oxaliplatin scheme in treating carcinoma of colon and the influence on T lymphocyte cell subsets.Methods Ninty-five cases of carcinoma of colon were randomly divided into control group(47 cases)and observation group(48 cases).Cases of control group were given with oxaliplatin scheme.Based on control group,observation group was treated with Calf spleen extractive,1 time/d and for 8 weeks.Scores of life quality,incidence rate of adverse drug reaction,and clinical effect were compared between the two groups.The influence on T lymphocyte cell subsets was detected in two groups.Results Scores of symptoms of observation group were lower than control group,and scores of function were higher than control group(P〈0.01).Total effect rate of observation group was 89.58%,which was higher than control group as 70.21%(P 〈0.05).Incidence rate of adverse drug reaction of observation group was lower than control group,and incidence rate of gastrointestinal reaction,thrombocytopenia,and leukocytopenia was obviously lower than control group(P〈0.05).Levels of CD3+,CD4+ of observation group were higher,while CD8+ was lower,than control group after 3 months’ treatment(P〈0.01).Conclusion Efficacy of Calf spleen extractive combined with oxaliplatin scheme in treating carcinoma of colon is definite,and may be related to up-regulating T lymphocyte cell subsets
作者 孟玮 史晓宇 张敬 马峰 宗治国 赵峻峰 刘博 李占林 Meng Wei Shi Xiaoyu Zhang Jing et al(Department of Medical Oncology , the First Affiliated Hospital, Hebei North University, Zhangjiakou 075000, Chin)
出处 《中国煤炭工业医学杂志》 2017年第7期828-831,共4页 Chinese Journal of Coal Industry Medicine
基金 张家口市科技计划自筹经费项目(编号:1521104D)
关键词 小牛脾提取物 结肠癌 奥沙利铂方案 T淋巴细胞亚群 Calf spleen extractive Carcinoma of colon Oxaliplatin scheme T lymphocyte cell subsets
  • 相关文献

参考文献12

二级参考文献95

  • 1李俊,崔冰劼.卡培他滨联合奥沙利铂治疗中晚期结肠癌的临床研究[J].中国药物与临床,2012,12(S1):46-47. 被引量:8
  • 2高德荣,温珍平,王磊,韩雅玲,李红.斯普林治疗化疗所致骨髓抑制和改善生活质量的效果[J].现代肿瘤医学,2007,15(2):262-263. 被引量:10
  • 3Johnson JR,Temple R. Food and drug administration requirements for approval of new anti-cancer drugs[J]. Cancer Treat Rep, 1985,69(10) : 1155-1157. 被引量:1
  • 4Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30:a quality of life instrument for use in international clinical trials in oncology [J]. J Natl Cancer Inst, 1993,85 (5) : 365-376. 被引量:1
  • 5Aaronson NK, Cull A, Kaasa S, et al. The EORTC modular approach to quality of life assessment in ontology [J]. Int J Ment Health, 1994,23 (4):75-96. 被引量:1
  • 6Rodgers GM 3rd, Becket PS, Blinder M, et al. Cancer- and chemotherapy- induced anemia [ J ] J Natl Compr Canc Netw,2012,10(5) :628. 被引量:1
  • 7苏奕欣.卡培他滨联合奥沙利铂治疗老年晚期胃癌的临床观察[J].中国实用医学,2013,8(7):24-25. 被引量:1
  • 8宋学坤,谢敬东.奥沙利铂联合卡培他滨治疗结肠癌104例临床观察[J].中国现代药物运用,2013,7(11):136-137. 被引量:1
  • 9Elias D,Lefevre JH,Chevalier J,et al. Complete cytoreduetive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin [ J ]. J Clin Oncol, 2009,27 ( 5 ) : 681-685. 被引量:1
  • 10Hagendoorn J, van Lammeren G, Boerma D, et al. Cytore-ductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcino- matosis from colorectal and gastroin-testinal origin shows acceptable morbidity and high survival [ J ]. Eur J Surg Oncol,2009,35 (8) :833-837. 被引量:1

共引文献1831

同被引文献14

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部